Addex Therapeutics Ltd (ADXN:NASDAQ) closed at $3.01 on November 3, 2026, up 0.50% on the day. The stock trades 71.2% below its 52-week high of $10.43 and 17.4% above its 52-week low of $2.56. Over the past year, it lost 65.7%. Addex Therapeutics Ltd is part of the Health Care sector.
In 252 trading sessions since November 3, 2025, ADXN closed higher on 97 days (38%). Its best day was April 24, 2026 (+14.01%) and its worst was September 28, 2026 (-23.01%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 13 times.
Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.
Find more stocks like ADXN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.